Document is current

Any future updates will be listed below

Correction: Efficacy and safety of combination therapy Ezetimibe 10/rosuvastatin 40 in Egyptian patients at very high risk of atherosclerotic cardiovascular disease

Crossref DOI link: https://doi.org/10.1186/s43044-025-00690-8

Published Online: 2025-10-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark